Photo via Toronto Star

Teva to Host R&D Day on Wednesday, November 11 in New York City

Read the original at Toronto Star ↗
Cite

Teva to Host R&D Day on Wednesday, November 11 in New York City. (2026, October 12). Toronto Star. https://www.thestar.com/globenewswire/teva-to-host-r-d-day-on-wednesday-november-11-in-new-york-city/article_a34c55f5-afb4-5213-bc12-f89090c64578.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Toronto Star · collected 2026-10-12 · by GlobeNewswire, Inc.

Quick Summary

Teva Pharmaceutical Industries Ltd., an Israeli company, is hosting an R&D Day on November 11, 2026, in New York City from 8:30 a.m. to 12:30 p.m. Eastern Time. During the event, Teva’s leadership will discuss the company's research and development pipeline, potential value creation over the next five years, and its transformation strategy into an innovative biopharmaceutical company through the Pivot to Growth initiative.
Written by AI on 2026-10-12, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

On Wednesday, November 11, 2026, Teva Pharmaceutical Industries Ltd. will host an R&D Day in New York City from 8:30 a.m. to 12:30 p.m. Eastern Time. The company’s leadership plans to discuss its research and development pipeline, focusing on the near-term value creation potential over the next five years. Additionally, they aim to outline their transformation into an innovative biopharma company through their Pivot to Growth strategy. This event is significant as it provides investors and stakeholders with insights into Teva's future growth initiatives and strategies.

Written for “Teva R&D Day” on 2026-11-03, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Teva R&D Day
Economy/Business · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
4
sentences that state something as happening or true
Uncertain
0%
0 of 4 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Economy/Business
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-12 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Toronto Star · 11143 article(s) · 28 correction(s) detected
Running correction rate · 28 correction(s)
2026-10-31
Inmate's escape is just the latest problem for Tennessee's troubled prison system
2026-10-26
Correction
2026-10-24
Correction
2026-10-22
News Clarification for Oct. 22
2026-10-21
No. 6 Hoosiers try to for rare rebound at Michigan after turning the page on 22-game winning streak
2026-10-19
Driver’s License Suspensions for Court Debt Draw Scrutiny
2026-10-16
Amputations and cancer treatment delays: Lawmakers hear testimony on Mississippi prison healthcare
2026-10-16
UPDATE: Golconda Gold Releases Q3 2026 Production Update at Galaxy
2026-10-08
News Clarification for Oct. 8
2026-10-07
Correction
2026-10-05
Entertainment Correction for Oct. 5
2026-10-03
Tennessee's prisons chief is resigning after failed execution of Christa Pike
2026-09-28
Organizations call for Action to End the Deaths of Indigenous People in Custody
2026-09-27
Police memorial recognizes six officers killed in the line of duty in 2026
2026-09-27
UPDATE: WSP to host Power & Energy-focused investor event virtually only
2026-09-26
News Clarification for Sept. 27
2026-09-26
Former federal public servant seeks better pensions for injured workers
2026-09-25
News Corrections for Sept. 25
2026-09-25
She has not been charged. But the Project South allegations have branded her with a 'scarlet letter'
2026-09-24
Correction
2026-09-23
MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
2026-09-22
Costa Rican man complained of lack of care for diabetes before his death in ICE custody, family says
2026-09-22
Judges' grilling of accused men leads to sex assault and dangerous driving cases being overturned
2026-09-20
Jura Energy Corporation Provides Clarification Regarding Media Reports Concerning Its Petroleum Rights in Pakistan
2026-09-19
New details emerge about Toronto's guns-for-hire and the 'crash-out mission" that sparked the Project South investigation
2026-09-17
UPDATE: Osisko Critical Minerals Corporation Announces C$100 Million Private Placement of Special Warrants
2026-09-17
Alabama set to execute man for pawn shop killings months after his nitrogen gas execution blocked
2026-09-04
Orca Corrects Q3 Quarterly Dividend Announcement

Who wrote this

No reporter is named on this article, beyond the feed's “GlobeNewswire, Inc.”.

Topics

Israel NYSE TEL AVIV TEVA Teva Pharmaceutical Industries Ltd.

Subjects

TEVA ORG · 3× Israel GPE · 1× N.Y. GPE · 1× NYSE ORG · 1× New York GPE · 1× Pivot to Growth ORG · 1× TEL AVIV GPE · 1× Teva Pharmaceutical Industries Ltd. ORG · 1×

Narrative

At the R&D Day, Teva’s leadership will discuss its R&D pipeline, its near-term value-creation potential over the next five years, and Teva’s ongoing transformation into an innovative biopharma company through the Pivot to Growth strategy.
framing: assertive · carried by 1 article(s) · first seen 2026-10-12
🔮 Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will host an R&D Day on Wednesday, November 11, 2026.
2026-10-12 · Toronto Star
Teva to Host R&D Day on Wednesday, November 11 in New York City · assertive framing

Claims (4 extracted, 0 hedged)

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will host an R&D Day on Wednesday, November 11, 2026. asserted
it → announce → Wednesday
At the R&D Day, Teva’s leadership will discuss its R&D pipeline, its near-term value-creation potential over the next five years, and Teva’s ongoing transformation into an innovative biopharma company through the Pivot to Growth strategy. asserted
leadership → discuss → strategy
The event will take place in New York, N.Y. asserted
event → take → York
Presentations will begin at 8:30 a.m. Eastern Time and are expected to conclude at 12:30 p.m. Eastern Time. asserted
Presentations → begin → p.m.
💬Give feedback
🕘History 🎫Support
Terms · Privacy · beta v2.0.0
Articles to 3 Nov 2026